Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | v-ets avian erythroblastosis virus E26 oncogene homolog | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | fli-1 protein | 0.0265 | 0.6568 | 0.6466 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0394 | 1 | 1 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0087 | 0.1811 | 0.0951 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0951 | 0.0951 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0394 | 1 | 1 |
Brugia malayi | Fli-1 protein | 0.0265 | 0.6568 | 0.6568 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0288 | 0.5 |
Schistosoma mansoni | gabp alpha | 0.0087 | 0.1811 | 0.0951 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0394 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.1472 | 0.1219 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0087 | 0.1811 | 0.0951 |
Brugia malayi | Ets-domain containing protein | 0.0087 | 0.1811 | 0.1811 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0288 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0394 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0394 | 1 | 1 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0087 | 0.1811 | 0.1568 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0394 | 1 | 1 |
Brugia malayi | Ets-domain containing protein | 0.0087 | 0.1811 | 0.1811 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0394 | 1 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0394 | 1 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0394 | 1 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0394 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0394 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0394 | 1 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0288 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.0288 | 0.0288 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0394 | 1 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0394 | 1 | 1 |
Schistosoma mansoni | ets-related | 0.0265 | 0.6568 | 0.6207 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0394 | 1 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0951 | 0.0682 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0394 | 1 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0394 | 1 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0394 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0394 | 1 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0394 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.4467 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 28.1838 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 112.2018 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction: HTRF assay against cherry picks. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.